Abstract

BackgroundLymphatic filariasis (LF) is a globally significant disease, with 1.3 billion persons in 83 countries at risk. A coordinated effort of administering annual macrofilaricidal prophylactics to the entire at-risk population has succeeded in impacting and eliminating LF transmission in multiple regions. However, some areas in the South Pacific are predicted to persist as transmission sites, due in part to the biology of the mosquito vector, which has led to a call for additional tools to augment drug treatments. Autocidal strategies against mosquitoes are resurging in the effort against invasive mosquitoes and vector borne disease, with examples that include field trials of genetically modified mosquitoes and Wolbachia population replacement. However, critical questions must be addressed in anticipation of full field trials, including assessments of field competitiveness of transfected males and the risk of unintended population replacement.Methodology/Principal FindingsWe report the outcome of field experiments testing a strategy that employs Wolbachia as a biopesticide. The strategy is based upon Wolbachia-induced conditional sterility, known as cytoplasmic incompatibility, and the repeated release of incompatible males to suppress a population. A criticism of the Wolbachia biopesticide approach is that unintended female release or horizontal Wolbachia transmission can result in population replacement instead of suppression. We present the outcome of laboratory and field experiments assessing the competitiveness of transfected males and their ability to transmit Wolbachia via horizontal transmission.Conclusions/SignificanceThe results demonstrate that Wolbachia-transfected Aedes polynesiensis males are competitive under field conditions during a thirty-week open release period, as indicated by mark, release, recapture and brood-hatch failure among females at the release site. Experiments demonstrate the males to be ‘dead end hosts’ for Wolbachia and that methods were adequate to prevent population replacement at the field site. The findings encourage the continued development and extension of a Wolbachia autocidal approach to additional medically important mosquito species.

Highlights

  • Lymphatic filariasis (LF) is a disfiguring and socioeconomically burdensome disease estimated to affect over 120 million people worldwide, with 1.3 billion people at risk [1]

  • Control crosses for female fertility consisted of 10 males and 10 females of CP, A. polynesiensis, A. albopictus, or A. aegypti

  • CP males were added to cages containing virgin A. polynesiensis, A. albopictus and A. aegypti females

Read more

Summary

Introduction

Lymphatic filariasis (LF) is a disfiguring and socioeconomically burdensome disease estimated to affect over 120 million people worldwide, with 1.3 billion people at risk [1]. An ongoing global strategy for eliminating this mosquito borne disease is to interrupt transmission by administering annual macrofilaricidal prophylactics through mass drug administration (MDA) programs. In the South Pacific, the pattern of negative density dependent transmission displayed by the primary vector, Aedes polynesiensis makes this mosquito more efficient in low-level microfilaraemics [2,3]. This complication has been hypothesized as a contributor to an inability to eliminate LF in the some areas of South Pacific, despite decades of ongoing MDA [2,4]. Critical questions must be addressed in anticipation of full field trials, including assessments of field competitiveness of transfected males and the risk of unintended population replacement

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call